70017-27-5

Basic information

• Product Name: 2-Propenal, 3-(2,4-dichlorophenyl)-, (E)-
• CAS NO: 70017-27-5
• Molecular Formula: C9H6Cl2O
• Molecular Weight: 201.052
• Mol File: 70017-27-5.mol

Chemical Properties

• CAS DataBase Reference: 2-Propenal, 3-(2,4-dichlorophenyl)-, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propenal, 3-(2,4-dichlorophenyl)-, (E)-(70017-27-5)
• EPA Substance Registry System: 2-Propenal, 3-(2,4-dichlorophenyl)-, (E)-(70017-27-5)

Safety Data

• Hazardous Substances Data: 70017-27-5(Hazardous Substances Data)

Upstream product

• 20595-45-3 2,4-dichlorocinnamic acid 
• 98581-93-2 3-(2',4'-dichlorophenyl)propionaldehyde 
• 3054-95-3 acrylaldehyde diethyl acetal 
• 29898-32-6 2,4-dichloro-1-iodo-benzene 
• 874-42-0 2,4-dichlorobenzaldeyhde 
• 75-07-0 acetaldehyde 

Downstream Products

• 1346682-13-0 (E)-1-(3-bromoprop-1-enyl)-2,4-dichlorobenzene 
• 148775-23-9 (2E)-3-(2,4-dichlorophenyl)prop-2-en-1-ol 
• 1169949-29-4 (3S,4R)-9-benzyl-4-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-1H-carbazole-3-carbaldehyde 
• 1169949-05-6 (3S,4R)-9-benzyl-4-(2,4-dichlorophenyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazole-3-carbaldehyde 
• 1169949-27-2 (3S,4R)-9-benzyl-4-(2,4-dichlorophenyl)-6-methoxy-2,3,4,9-tetrahydro-1H-carbazole-3-carbaldehyde 
• 1280199-16-7 (E)-1,1,1-trichloro-4-(2,4-dichlorophenyl)but-3-en-2-one 
• 1280199-27-0 (4S,6S)-4-(2,4-dichlorophenyl)-6-hydroxy-2-phenyl-6-(trichloromethyl)-5,6-di-hydro-4H-pyran-3-carbonitrile 

Relevant articles and documents

Iron-Catalyzed ?±,?-Dehydrogenation of Carbonyl Compounds

An iron-catalyzed α,β-dehydrogenation of carbonyl compounds was developed. A broad spectrum of carbonyls or analogues, such as aldehyde, ketone, lactone, lactam, amine, and alcohol, could be converted to their α,β-unsaturated counterparts in a simple one-step reaction with high yields.

CARBOLINE ANTIPARASITICS

The present invention provides Formula (1 ) compounds that are gamma-carbolines, Formula (1) wherein R1 a, R1 b, R1 c, R1d, R2, R3, and "— " are as defined herein; veterinary acceptable salts thereof, and stereoisomers thereof, which act as parasiticides,

Organocatalytic enantioselective multicomponent synthesis of pyrrolopiperazines

The first organocatalytic multicomponent synthesis of enantioenriched pyrrolopiperazines is reported. These biologically relevant fused tricyclic products were obtained under catalytic iminium activation through a reaction sequence involving an enantioselective Michael addition followed by an iminium ion trapping via Pictet-Spengler cyclization (MAPS sequence). Substantial possibilities for variation on the three reaction partners [β-keto ester, enal and N-(2-aminoethyl)pyrrole] along with excellent enantioselectivities are the highlights of the present transformation.

NOVEL SPIROINDOLINE COMPOUNDS

This invention relates to novel spiroindoline compounds of formula (I) that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of said compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.

Direct oxidative conversion of 3-aryl propionaldehydes to 3-aryl acroleins promoted by SOMO catalysis

A new direct oxidative transformation of 3-aryl propionaldehydes to 3-aryl acroleins promoted by SOMO catalysis has been realized with high efficiency under mild reaction conditions.

Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands

Based on 3-phenylpropionamides, a series of 3-arylpyrrolidine-2-carboxamide derivatives was designed and synthesized to study the effect of cyclizations as melanocortin-4 receptor ligands. It was found that the 2R,3R-pyrrolidine isomer possessed the most

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives

A series of 5-substituted 3,5-dihydroxypentanoic acids and their derivatives have been prepared and tested for inhibition of HMG-CoA reductase in vitro. In general, unless a carboxylate anion can be formed and the hydroxy groups remain unsubstituted in an erythro relationship, inhibitory activity is greatly reduced. Furthermore, only one enantiomer of the ring-opened form of lactone 6a(±) possesses the activity displayed by the racemate. Insertion of a bridging unit other than ethyl or (E)-ethenyl between the 5-carbinol moiety and an appropriate lipophilic moiety (e.g., 2,4-dichlorophenyl) attenuates activity.